Science
Research is a key strength for Biogen Idec. Biogen Idec's goal is to enhance its therapeutic areas of oncology, neurology, dermatology and immunology.
Biogen Idec is a leading global biotechnology company, with an R&D budget of approximately 30% of 2008 revenues. The company's research is closely integrated with its commercial strengths, with leading-edge research in oncology, immunology and neurobiology. Additional discovery and development efforts are aimed at adding substantial value to Biogen Idec's existing products by extending their use to other diseases.
Biogen Idec has established two research centers: one in Cambridge, Massachusetts and the other in San Diego, California. This capability is supplemented with selective alliances with both other companies and academic research groups aimed at helping Biogen Idec continue to meet future challenges.